HHS Says FDA Working With Baxter To Identify Potential Products In System, Alternative Manufacturing Sites, Including For Potential Temporary Imports; FDA Will Continue To Work With Baxter As They Bring Their Plant Back Online And With Other Suppliers...
HHS Says FDA Working With Baxter To Identify Potential Products In System, Alternative Manufacturing Sites, Including For Potential Temporary Imports; FDA Will Continue To Work With Baxter As They Bring Their Plant Back Online And With Other Suppliers...
衛生與公衆服務部表示，美國食品藥品監督管理局正在與百特公司合作，確定系統中潛在的產品，備選製造場所，包括潛在的臨時進口；美國食品藥品監督管理局將繼續與百特公司合作，協助其重新啓動工廠，並與其他供應商合作...
HHS Says FDA Working With Baxter To Identify Potential Products In System, Alternative Manufacturing Sites, Including For Potential Temporary Imports; FDA Will Continue To Work With Baxter As They Bring Their Plant Back Online And With Other Suppliers To Increase Supply
衛生部表示，FDA正在與Baxter合作，確定系統中的潛在產品，替代製造地點，包括潛在的臨時進口；FDA將繼續與Baxter合作，幫助他們重新上線工廠，並與其他供應商合作，增加供應
- Reuters
-路透社
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間